Search

Search Constraints

You searched for: Author/Creator Iwaizumi, M.

Search Results

2. Potent acid inhibition by vonoprazan in comparison with esomeprazole, with reference to CYP2C19 genotype. Issue 10 (18th March 2016)

3. Twice‐daily dosing of esomeprazole effectively inhibits acid secretion in CYP2C19 rapid metabolisers compared with twice‐daily omeprazole, rabeprazole or lansoprazole. Issue 9 (16th September 2013)